Nevertheless, the fact that the PD-1 rs7421861 A>G and PD-L1 rs2282055 T>G polymorphisms correlate with the severity of cancer probably suggests that these polymorphisms are associated with clinical outcomes among breast cancer patients. This evidence concerns the gene CD274 and breast carcinoma.